Read the full interview:
We are proud to be recognized as one of Switzerland's most promising scale-ups in 2023.
Read morePulmonary fibrosis is a chronic and usually fatal disease. The project will investigate the anti-fibrotic effects of TOP-V122.
Read moreTOP-N53: A Clinical Drug Candidate for the Treatment of Non-healing Wounds.
Read more